This article highlights the top business leaders to watch in 2025, each of whom is redefining what it means to lead in today’s complex and ever-evolving global landscape.
Eculizumab is under clinical development by Alexion Pharmaceuticals and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Acute Lung Injury.